These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26963025)

  • 21. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
    Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
    Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
    Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
    J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Tanida M; Ono Y; Kasahara R; Fujii Y; Ohora K; Suzuki K; Sobue K
    Biochem Biophys Res Commun; 2014 Feb; 445(1):214-7. PubMed ID: 24508800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombospondin-1 prevents amyloid beta-mediated synaptic pathology in Alzheimer's disease.
    Son SM; Nam DW; Cha MY; Kim KH; Byun J; Ryu H; Mook-Jung I
    Neurobiol Aging; 2015 Dec; 36(12):3214-3227. PubMed ID: 26452999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-degrading enzyme is not secreted from cultured cells.
    Song ES; Rodgers DW; Hersh LB
    Sci Rep; 2018 Feb; 8(1):2335. PubMed ID: 29402917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of β-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes.
    García-Juan M; Ordóñez-Gutiérrez L; Wandosell F
    Glia; 2024 Mar; 72(3):588-606. PubMed ID: 38009275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy-dependent secretion: mechanism, factors secreted, and disease implications.
    New J; Thomas SM
    Autophagy; 2019 Oct; 15(10):1682-1693. PubMed ID: 30894055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinases A and C regulate amyloid-β degradation by modulating protein levels of neprilysin and insulin-degrading enzyme in astrocytes.
    Yamamoto N; Nakazawa M; Nunono N; Yoshida N; Obuchi A; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neurosci Res; 2021 May; 166():62-72. PubMed ID: 32512031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy-Mediated Secretory Pathway is Responsible for Both Normal and Pathological Tau in Neurons.
    Kang S; Son SM; Baik SH; Yang J; Mook-Jung I
    J Alzheimers Dis; 2019; 70(3):667-680. PubMed ID: 31256134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
    Vingtdeux V; Chandakkar P; Zhao H; Blanc L; Ruiz S; Marambaud P
    J Cell Sci; 2015 Jul; 128(13):2330-8. PubMed ID: 25999473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
    Hook VY; Reisine TD
    J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.
    Zhao J; Li L; Leissring MA
    Mol Neurodegener; 2009 Jan; 4():4. PubMed ID: 19144176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
    Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
    Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Arima H; Naruse K; Kasahara R; Taniura H; Hirate H; Sugiura T; Suzuki K; Sobue K
    Neurosci Lett; 2013 Jun; 545():54-8. PubMed ID: 23624023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.